Glimipack MV 1/0.3 Tablet SR
Marketer
Koye Pharmaceuticals Pvt ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Glimipack MV 1/0.3 Tablet SR
Diabetacomb 1/0.3 SR tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes. This medication helps regulate blood glucose in diabetic patients. Diabetacomb 1/0.3 SR tablets should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with well-managed blood sugar, as discontinuation without medical supervision risks elevated blood glucose, potentially leading to kidney complications, vision loss, neuropathy, and limb damage. This medication is one component of a comprehensive diabetes management plan, which includes a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to identify hypoglycemic symptoms—sweating, lightheadedness, headache, tremors—and how to treat them. Maintain consistent mealtimes and always carry a fast-acting glucose source, such as candy or juice. Alcohol consumption elevates hypoglycemia risk and should be minimized. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Individuals with a history of heart disease should inform their physician before starting treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.
Primary Ingredients of Glimipack MV 1/0.3 Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Glimipack MV 1/0.3 Tablet SR
Managing type 2 diabetes
Major Benefits of Glimipack MV 1/0.3 Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimipack MV 1/0.3 Tablet SR on an empty stomach.
Common Side effects of Glimipack MV 1/0.3 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimipack MV 1/0.3 Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimipack MV 1/0.3 Tablet SR on an empty stomach.
How Glimipack MV 1/0.3 Tablet SR works:
Glimipack MV 1/0.3 sustained-release tablets contain a triple combination of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimipack MV 1/0.3 Tablet SR and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glimipack MV 1/0.3 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimipack MV 1/0.3 tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Glimipack MV 1/0.3 Tablet SR is inadvisable for individuals with kidney impairment and should be strictly avoided. Patients with severe kidney disease are especially cautioned against its use; a physician's consultation is essential.
LiverCAUTION
Patients with liver impairment should use Glimipack MV 1/0.3 Tablet SR cautiously, potentially requiring dose modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should involve a low dose; however, it's contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimipack MV 1/0.3 Tablet SR :
Should you forget to take a Glimipack MV 1/0.3 Tablet SR, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Glimipack MV 1/0.3 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently